Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+153.4%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+153.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
16.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$404.39M+137.7%
2024$170.13M+973.1%
2023$15.85M-36.2%
2022$24.86M-54.8%
2021$54.95M+22438.2%
2020$-246000.00-232.4%
2019$-74000.00-7300.0%
2018$-1000.00-